Alkylating agents‐induced gonadotoxicity in prepubertal males: Insights on the clinical and preclinical front
Open Access
- 4 July 2024
- journal article
- review article
- Published by Wiley in Clinical and Translational Science
- Vol. 17 (7) , e13866
Abstract
Rising cure rates in pediatric cancer patients warrants an increased attention toward the long‐term consequences of the diagnosis and treatment in survivors. Chemotherapeutic agents can be gonadotoxic, rendering them at risk for infertility post‐survival. While semen cryopreservation is an option that can be provided for most (post)pubertal boys before treatment, this is unfortunately not an option prepubertal in age, simply due to the lack of spermatogenesis. Over the last couple of years, studies have thus focused on better understanding the testis niche in response to various chemotherapeutic agents that are commonly administered and their direct and indirect impact on the germ cell populations. These are generally compounds that have a high risk of infertility and have been classified into risk categories in curated fertility guidelines. However, with it comes the lack of evidence and the challenge of using informative models and conditions most reflective of the physiological scenario, in short, the appropriate study designs for clinically relevant outcomes. Besides, the exact mechanism(s) of action for many of these “risk” compounds as well as other agents is unclear. Understanding their behavior and effect on the testis niche will pave the way for incorporating new strategies to ultimately combat infertility. Of the various drug classes, alkylating agents pose the highest risk of gonadotoxicity as per previously established studies as well as risk stratification guidelines. Therefore, this review will summarize the findings in the field of male fertility concerning gonadotoxicity of akylating agents as a result of chemotherapy exposure.Keywords
This publication has 164 references indexed in Scilit:
- Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for ewing and soft tissue sarcomasCancer, 1992
- Conditioning for allogeneic marrow transplantation in patients with lymphohematopoietic malignancies without the use of total body irradiation.1992
- Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignanciesBlood Reviews, 1992
- Serum Levels of Immunoreactive Inhibin, FSH, and LH in Human Infants at Preterm and Term BirthNeonatology, 1992
- Testikuläre Funktion nach OPA / COMP-Chemotherapie ohne Procarbazin bei Jungen mit Morbus HodgkinKlinische Padiatrie, 1991
- Testicular function following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up studyPediatric Nephrology, 1990
- The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescenceCancer, 1990
- Reproductive Effects of the Anticancer Drug Cyclophosphamide in Male Rats at Different AgesArchives of Andrology, 1989
- Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndromeThe Journal of Pediatrics, 1978
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977